Literature DB >> 22253524

Prognostic relevance of circulating CK19 mRNA in advanced malignant biliary tract diseases.

Kawin Leelawat1, Siriluck Narong, Wandee Udomchaiprasertkul, Jerasak Wannaprasert, Sa-ard Treepongkaruna, Somboon Subwongcharoen, Tawee Ratanashu-ek.   

Abstract

AIM: To determine the role of circulating tumor cells (CTCs) in prediction of the overall survival of patients with advanced malignant biliary tract obstruction.
METHODS: We investigated the prognostic value of CTCs by examining two markers, cytokeratin (CK) 19 and human telomerase reverse transcriptase (hTERT) mRNA, in 40 patients diagnosed with advanced malignant biliary tract diseases. Quantitative real-time reverse transcription polymerase chain reaction was used to detect CK19 and hTERT mRNA in the peripheral blood of these patients. Overall survival was analyzed using the Kaplan-Meier method and Cox regression modeling.
RESULTS: Positive CK19 and hTERT mRNA expression was detected in 45% and 60%, respectively, of the 40 patients. Univariable analysis indicated that positive CK19 mRNA expression was significantly associated with worse overall survival (P = 0.009). Multivariable analysis determined that positive CK19 mRNA expression, patient's age and serum bilirubin were each independently associated with overall survival.
CONCLUSION: CK19 mRNA expression levels in peripheral blood appear to provide a valuable marker to predict the overall survival of patients with advanced malignant biliary tract obstruction.

Entities:  

Keywords:  Circulating tumor cells; Cytokeratin 19; Human telomerase reverse transcriptase; Malignant biliary tract obstruction; Overall survival

Mesh:

Substances:

Year:  2012        PMID: 22253524      PMCID: PMC3257445          DOI: 10.3748/wjg.v18.i2.175

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  REporting recommendations for tumor MARKer prognostic studies (REMARK).

Authors:  Lisa M McShane; Douglas G Altman; Willi Sauerbrei; Sheila E Taube; Massimo Gion; Gary M Clark
Journal:  Nat Clin Pract Oncol       Date:  2005-08

Review 3.  Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction.

Authors:  Alan C Moss; Eva Morris; Jan Leyden; Padraic MacMathuna
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-12       Impact factor: 2.566

4.  Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.

Authors:  Panthip Rattanasinganchan; Kawin Leelawat; Sa-ard Treepongkaruna; Chintana Tocharoentanaphol; Somboon Subwongcharoen; Tuangporn Suthiphongchai; Rutaiwan Tohtong
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

5.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

6.  Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study.

Authors:  Mehdi Kaassis; Jean Boyer; Rémi Dumas; Thierry Ponchon; Dimitri Coumaros; Richard Delcenserie; Jean-Marc Canard; Jacques Fritsch; Jean-François Rey; Pascal Burtin
Journal:  Gastrointest Endosc       Date:  2003-02       Impact factor: 9.427

Review 7.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

8.  HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.

Authors:  Pia Wülfing; Julia Borchard; Horst Buerger; Stefan Heidl; Kurt S Zänker; Ludwig Kiesel; Burkhard Brandt
Journal:  Clin Cancer Res       Date:  2006-03-15       Impact factor: 12.531

9.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.

Authors:  K Knyrim; H J Wagner; J Pausch; N Vakil
Journal:  Endoscopy       Date:  1993-03       Impact factor: 10.093

10.  Prognostic relevance of carbohydrate antigen 19-9 levels in patients with advanced biliary tract cancer.

Authors:  Jan Harder; Oliver Kummer; Manfred Olschewski; Florian Otto; Hubert Erich Blum; Oliver Opitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-10       Impact factor: 4.254

View more
  3 in total

1.  Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.

Authors:  Abeer A Bahnassy; Abdel-Rahman N Zekri; Ahmed El-Bastawisy; Amal Fawzy; Marwa Shetta; Nehal Hussein; Dalia Omran; Abdallah A S Ahmed; Samir S El-Labbody
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand.

Authors:  Supinda Koonmee; Sakkarn Sangkhamanon; Piyapharom Intarawichian; Chaiwat Aphivatanasiri; Waritta Kunprom; Prakasit Sa-Ngiamwibool; Suwit Balthaisong; Chitsakul Phuyao; Piya Prajumwongs; Reza Alaghehbandan; Malinee Thanee
Journal:  Front Public Health       Date:  2022-06-10

Review 3.  Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Authors:  Gianluca Rompianesi; Marcello Di Martino; Alex Gordon-Weeks; Roberto Montalti; Roberto Troisi
Journal:  World J Gastrointest Oncol       Date:  2021-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.